Activation of distinct receptor tyrosine kinases (RTK), such as the products of the c-fms and c-kit proto-oncogenes, profoundly affects hematopoietic development. We have isolated a novel RTK cDNA, called met-related kinase (MRK), which is expressed on early erythroid progenitors. MRK is also expressed in many hematopoietic cell lines, and is not lineage restricted. Several regions within the EMATOPOIETIC development is controlled by ex-
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H tracellular signals that ultimately regulate lineagespecific programs. Cytokines participate in this process by binding to specific cell-surface receptors on stem cell and progenitor pools, signaling proliferation and differentiation. Several broad classes of receptors have been defined on hematopoietic cells. One cytokine receptor superfamily, which includes the receptors for many of the interleukins and erythropoietin, is characterized by four extracellular cysteine moieties, a WSXWS motif, and a single transmembrane domain.' Another class is characterized by a single transmembrane domain and a cytoplasmic region homologous to the protein tyrosine kinases, such as c-src.'" Some receptor tyrosine kinases (RTK) are expressed on distinct lineages of hematopoietic cells. For instance, macrophage colony-stimulating factor (M-CSF) binds to a lineage-restricted RTK, the product of the c-fms proto-~ncogene.~ The activation of c-fms leads to monocyte differentiation. The c-kit proto-oncogene, another RTK, is critical for early hematopoiesis.6-8 Signaling of this receptor leads to a proliferative response and also stimulates mast cell differentiation.'-" Thus, activation of specific RTKs is likely to represent fundamental steps in normal hematopoiesis.
Studies using degenerate oligonucleotide polymerase chain reaction (PCR) have led to the isolation of several novel RTKs that are expressed on hematopoietic cells"-L5; however, the function of these receptors is currently unknown and ligands are not available. The murine flk-2I6 (or the human homolog flt3I7-l9) receptor was originally isolated from hematopoietic stem cells and may be an early signal for self-renewal or proliferation. Subsequently, it was found that murine flk-2 is expressed in nervous system, skin, gonads, and placenta. The receptors flk-2, c-fms, and c-kir are structurally similar to each other, with five Ig domains in the extracellular domain. The receptors flt l ,*' flk-1 ,'I and flt422,23 are members of another distinct subset of the RTK superfamily that are expressed on hematopoietic cells, and are characterized by the presence of seven Ig domains in the extracellular domain. The receptor fltl was originally isolated from a placenta cDNA library, and was found to be expressed in many tissues.'' It has recently been shown to be capable of binding vascular endothelial growth factor (VEGF) with high affinit~.'~ VEGF has also been shown to stimulate monocyte procoagulant activity and to promote monocyte migration through vascular endothel i~m . '~ The targets of VEGF therefore seem confined to vascular endothelial cells and hematopoietic cells. The flk-1 receptor was originally isolated from hematopoietic stem cell populations and is expressed in many tissues (fetal and adult), including hematopoietic stem cells, brain, kidney, heart, spleen, muscle, and lung." The flt4 RTK was recently isolated from a HEL cDNA library, and is expressed in human placenta, lung, heart, and kidney.22,23 Another RTK, called c-axl, was originally isolated from chronic myelogenous leukemic cells, and was subsequently found to have transforming activity in NIH 3T3 cells.26 It is expressed in many cell lines of epithelial, mesenchymal, and hematopoietic origin. Recently, signaling of hepatocyte growth factor receptor (the c-met proto-oncogene) on bone marrow cells has been shown to act synergistically with interleukin-3 (IL-3) and granulocyte-macrophage (GM)-CSF in colony-forming assays." Other more general RTKs are also expressed on hematopoietic cells such as the receptor for insulinlike growth factor I (IGF-I).28,29 Triggering of IGF-I receptors have been shown to support colony growth in vitro and prevent programmed cell death. Therefore, hematopoietic cells seem to be a rich source of RTKs.
Signaling of some widely expressed receptors leads to activation of distinct cell-specific programs. For instance, the c-kit receptor is expressed in other tissues including brain and primordial germ ~ells.~,~',~' Mutations in the c-kit receptor, characterized as the W-locus in the mouse model, lead to deafness and sterility in addition to its effects of anemia and mast cell deficiency on hematopoietic tissues. Isolation of highly enriched erythroid progenitors. The method of Boyer et al was used to derive purified erythroid colony-forming units (CFU-E).28 Briefly, CFU-E were purified from BALB/c mouse spleens. Eleven spleens were harvested after an 84-hour recovery from thiamphenicol treatment with an average weight of 239 mg (k46 SD) and a yield of 4.10 X IO9 cells. After 30 mL/min elutriation and banding at p = 1.064 on Percoll density gradients, 1.65 X 10' cells were obtained,
Cell culture for determination of CFU-E number. The above erythroid cells were cultured in methyl cellulose for 48 hours. In the presence of 1 .O U/mL of erythropoietin in the media, 82% k 1% of the cells formed hemoglobinized colonies containing more than 8 cells each (CFU-E). Therefore, the final yield of CFU-E was calculated to be 4.90 X lo7.
Cells were either plated in T-150 flasks at a density of 0.5 to 1.0 X lo6 cells/mL of methyl cellulose media containing 1 .O U/mL erythropoietin (Amgen, Thousand Oaks, CA) or used immediately. After incubation at 37°C for various time intervals, cells were collected from methyl cellulose by dilution with phosphate-buffered saline (PBS), centrifuged, washed, and counted, and RNA was extracted from whole cells by guanidinium isothiocyanate extraction with the following modification^.^^ After the initial lysis and extraction with phenol/ chloroform, a second phenol/chloroform extraction was performed before ethanol precipitation. A second ethanol precipitation in the presence of sodium acetate purified the RNA from the guandinium RNA preparation from CFU-E in culcure.
salts and allowed more rapid solubilization of the RNA in water. Samples were stored at -80°C.
Degenerate oligonucleotide PCR for protein tyrosine kinases (PTKs). PTKI and PTKlI primers were previously described.'%'' As per the method of Wilks, reverse transcriptase-PCR was performed using I pg of total cellular RNA from purified CFU-E. The PCR program used in a Perkin-Elmer Thermocycler (Perkin Elmer-Cetus, Norwalk, CT) consisted of I minute at 9 4 T , 1 minute at 3 7 T , and 3 minutes at 63°C for 30 cycles, and a final 7-minUte extension. The resultant PCR products were digested with EcoRI and BamHI enzymes for 2 hours at 37°C and electrophoresed through a I% agarose gel. The products were visualized by staining with ethidium bromide, cut from the gel, placed in a Spinex column (Costar, Cambridge, MA), and centrifuged at 14,000 RPM at 4°C. The collected effluent was ethanol precipitated in the presence of 10 p g of yeast tRNA as carrier, resuspended in water, and ligated in the Bluescript I1 SK-vector (Stratagene, LaJolla, CA). Thirty-one cDNA clones derived from the PCR reaction were grown at 37°C in Luria-Bertami (LB) broth; DNA was prepared and subjected to DNA sequencing (Sequenase kit; US Biochemicals, Cleveland, OH).
Isolation of a full-length cDNA. One of the cDNAs obtained (called PTK 7) was found to encode a novel RTK. This cDNA insert was excised from the Bluescript vector and used as a probe. Filters bearing 1 million plaques from a murine erythroleukemia (MEL) and 1 million plaques from a CFU-E cDNA library were screened at high stringency according to standard technique^.^' After plaque purification, cDNA inserts for MRK were subcloned into pUC-18 for sequencing. Eight cDNA clones were isolated, and only the longest clone (Fig 1) was fully characterized.
RNaseprotection analysis. To quantitate the changing amount of ,!Y"-globin mRNA, radiolabelled P""-globin RNA was synthesized as described by Bender Northern blot analysis. For hematopoietic cells and purified erythroid progenitors, 10 p g oftotal cellular RNA isolated as above was loaded per lane. Standard methods were used for transfer to Magnagraph membrane (Micron Separation Inc, Westborough, MA) and subsequent hybridi~ation.~' After MRK probe hybridization, each blot was stripped of radioactivity and reprobed with a 0-actin PCR fragment. For tissue expression analysis, a Multiple Tissue Northern (Collaborative Research, Bedford, MA) contained 10 p g of polyA+ RNA from each tissue, and hybridization was performed under similar stringency as above using the provided instructions.
Poly(A)+ RNA was prepared from 2 X lo7 MEL cells using a single-step extraction kit (Invitrogen, San Diego, CA). RNA was incubated for 1 hour at 37°C in a reaction buffer containing Moloney murine virus RT (Bethesda Research Laboratories, Bethesda, MD) and a 37-bp 32P-labeled oligonucleotide was derived from the complementary strand of nt 50-85 of the MRK cDNA (Fig 1) . After phenol/chloroform extraction and ethanol precipitation, the sample was electrophoresed on an 8% polyacrylamide gel, and the size of the prominent radiolabeled DNA fragment extended onto the primer was determined.
Specific antisera was generated to a fusion protein of glutathion-S-transferase and the C-terminal 4 I amino acids of MRK using the PGEX system (Pharmacia Fine Chemicals, Uppsala, Sweden). The bacterial expression construct was generated by PCR. A PCR primer (MRK/BAM) was generated Primer extension.
Preparation of specific antisera.
For personal use only. that represented nucleotides 1805 to 1827, including a BamHI cloning site (5'-AAGCTAGG ATCCTGCCCTGATGA ACTGTTT-GCTG-3'). One microgram of the MRK/Bluescript cDNA clone was used as a template for a PCR reaction using MRK/BAM as a 5' primer and the T3 primer of the Bluescript KS 11-(Stratagene) vector arm as 3' primer. The PCR conditions included 30 cycles of 94°C denaturation for 1 minute, 55°C annealing for 1 minute, and 72°C extension for 1 minute. followed by a 7-minute 72°C extension. The PCR product was cloned into the PGEXZ vector using BamHI and EcoRI sites.
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MRIC-GST fusion proteins were generated using the protocol by Kaelin et al?' A 100-mL culture of the PGEX 2TK-recombinant expressing fusion was grown overnight by shaking at 37°C. This culture was then diluted I: 10 in fresh LB/ampicilIin and grown for I hour at 37°C. IPTG was added at a concentration ofO. 1 mmol/L, and the culture was incubated for an additional 4 hours at 37°C. The bacteria was pelleted and resuspended in 80 mL of cold NETN (0.5% NP-40,20 mmol/L Tris (8.0), 100 mmol/L NaCl, I mmol/L EDTA) with protease inhibitors (1 mmol/L DTT, 0.1 mg/mL of PMSF, 1/250 dilution of Aprotinin [Sigma Chemical Company, St Louis, MO]). Ten-milliliter aliquots were sonicated on ice, and the suspension was centrifuged at 10,OOOg for 5 minutes at 4°C. Two hundred microliters of Glutathione sepharose beads (Pharmacia, Piscataway, NJ), resuspended 1:l in NETN + 0.5% milk (Carnation), was added to 10 mL of sonicate supernatant. The solutions were rocked at 4°C for 30 minutes, and the beads were washed three times with ice-cold NETN and placed on a Poly Prep Chromatography column (Bio-Rad Laboratories, Richmond, CA). The protein was eluted in 10 1-mL fractions by adding I-mL aliquots of 20 mmol/L glutathione (Boehringer Manneheim, Germany) in 100 mmol/L Tris, pH 8.0, 120 mmol/L NaCI. Thirty microliters of each fraction was electrophoresed through a 15% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gel using a Hoefer Mighty Small I1 Western apparatus (Hoefer Scientific Instruments, San Francisco, CA). The gel was stained using Comassie Blue for 5 minutes and destained overnight. The two fractions with highest yields were pooled. Approximately 500 pg of purified fusion protein was eluted. Two rabbits were initially immunized with 250 pg of peptide, and subsequently given monthly boosts of 50 pg. Test bleeds were obtained at 6 weeks after initial injection, and subsequently, large-scale bleeds were obtained monthly.
COS cell transfection and membrane preparation. MRK/PXM plasmid (20 pg) was transfected into COS cells (at 50% to 75% confluence) by the diethyl aminoethyl (DEAE) dextran/chloroquine method.42 The PXM plasmid (20 pg) without a cDNA insert was used in mock transfections. Fresh medium was added 24 hours posttransfection. At 48 hours posttransfection, the COS cells were washed twice in ice-cold PBS, scraped from the plate in 5 mL of PBS and centrifuged at 600g for 5 minutes at 4°C. Plasma membranes were prepared using the method described by Bischoff et al. 43 Cells were resuspended in 5 mL of a HEPES/sucrose buffer (10 mmol/L HEPES, pH 7.4,0.2 mol/L sucrose), and pelleted at 6008 for 5 minutes at 4°C. The pellet was resuspended in 1 mL of HEPES/sucrose buffer, incubated on ice for IO minutes, and disrupted using 50 to 100 strokes in a dounce homogenizer. Nuclei were pelleted by centrifugation at 600g for 10 minutes at 4°C. The supernatant was transferred to a tube and spun at 200,OOOg for 15 minutes in a Beckman TL-100.2 fixed-angle rotor (Beckman Instruments, Irvine, CA) at 4°C. The pellet was resuspended in 100 pL (for Western blot analysis) or 500 pL (for immunoprecipitation analysis) of Buffer D (1 50 mmol/L NaCl, 10 mmol/L NaP04 [pH 7.61, 2.5 mmol/L EDTA, 0.5% NP-40, 0.1 % NaDOC, 0.1% SDS, 10% glycerol). Samples were stored at -70°C.
Western blot analysis. Thirty-five microliters of the membrane protein samples was boiled in sample buffer for 5 minutes and electrophoresed in an 8% SDS-PAGE gel. The proteins were transferred for 2 hours in an Electrotransfer Apparatus (Hoeffer) onto a nitrocellulose filter (Schleicher & Schuell, Keene, NH). The filters were blocked in a solution of 5% milk (Carnation)-TBST (150 mmol/L NaCI, 10 mmol/L Tris, pH 8, 0.05% Tween) for at least 1 hour at room temperature with rocking. The blot was subsequently incubated for another I to 2 hours with polyclonal rabbit antisera, described above, at a 1/500 dilution in 2.5% milk-TBST. The filters were washed five times for 5 minutes each in TBST, and incubated for 30 minutes with antirabbit Ig antisera coupled to alkaline phosphatase (Promega, Madison, WI) diluted 1/7,500 in a solution of 2.5% milk-TBST. The filters were washed five times for 5 minutes 
RESULTS
Isolalion of a cDNA encoding a novel RTK reccptor. One microgram of total cellular RNA obtained from purified CFU-E was subjected to PCR using degenerate oligonucleotides that are specific for PTKs."-'' The resultant PCR products were subcloned and 3 1 partial cDNAs were sequenced in their entirety. Three identical cDNAs encoded a novel RTK based on sequence homology. Subsequent to the initial isolation, other investigators have isolated an identical partial cDNA from cerebellar RNA," and a partial cDNA (JTK 5) obtained from K562 RNA seems to represent the human homolog.'* Also obtained in this screen were 14 cDNAs of the human homolog of JTKIO," I cDNA of the human homolog of JTK3." 1 HCK cDNA, and 2 serine-threonine kinases. Three of the cDNAs were a-globin and seven were not characterized.
Using the partial cDNA as a probe, MEL and CFU-E cDNA libraries were screened to obtain longer cDNAs. As shown in Fig I , the longest cDNA is 2,496 bp and predicts a RTK polypeptide of 66 Kd. A Kozak consensus sequence4' is present at the predicted translation initiation site, and an in-frame stop codon is located upstream ofthis ATG. ChouFasman plots demonstrated a hydrophobic region that predicts a single transmembrane domain from amino acid 2 1 I to 233.46 There are five potential N-glycosylation sites in the extracellular domain.
To determine whether the MRK cDNA obtained represents a full-length clone, primer extension analysis was performed. As shown in Fig 2, a 37 -mer oligonucleotide primer complementary to nucleotide 50 to 85 was annealed and extended. A band of 140 nt was evident. Taking into account the EcoRIlNot I cloning site, this indicates that MRK cDNA was 5 1 nt short of full length.
A search using the BLAST program4' demonstrated that the isolated RTK has amino acid similarity with several members of the family, including c -m~t , '~ c -~e a ,~' c-ax1,26 the fibroblast growth factor re~e p t o r ,~' the insulin re~eptor,'~ and the EGFR3*." (Fig 3) . Domains IV, V, VIII. and XI3 are more similar to c-inel and v-sea than other members of the family. The C-terminal region of the kinase from domains VI11 to XI is more similar to v-sea and c-ax1 than c-met. Based on the similarity to this subfamily of RTKs, we designated this cDNA MRK; however, the homology is limited and there is significant homology throughout the entire cytoplasmic tail with the other members listed. In domain I the structural motif GXGXXG is QXGXXG in MRK. This domain is adjacent to the consensus adenosine triphosphate (ATP) binding site, and the glutamic acid residue at position 1 ofthis motif may affect the regulation of this kinase.
Pattern of expression of MRK. Northern blot analysis demonstrated that MRK is ubiquitously expressed in many tissues of the body (Fig 4) . This includes expression in the heart, brain, spleen, lungs, muscle, liver, and kidney. Stomach and small intestines also express MRK (data not Homology to known RTKs. shown). For each tissue, 2.5-and 3.5-kb transcripts are evident. The etiology of these two transcripts remains to be determined, but may represent alternative polyadenylation or splicing. Northern blot analysis of many hematopoietic cell lines demonstrated that cell lines of various lineages express MRK (Fig 5) . However, the pattern of expression does not seem to be lineage-dependent, because MRK expression is detected in some megakaryocytic and mast cell lines and these. cells also express GATA-I and have some multipotential qualities (Zon, unpublished observations); BAF3 cells also fail to express MRK. However, both undifferentiated wild-type and GATA-I -deficient ES cell lines express abundant MRK RNA. MRK is expressed during the differeniiation of purified CFU-E. Most gene expression decreases as CFU-E maturation occurs.48 Northern blot analysis of total cellular RNA from CFU-E differentiated in the presence of erythropoietin over a period of 36 hours was used to examine the level of MRK expression during erythroid maturation. When compared with the level of @-actin, MRK levels are maintained throughout erythroid maturation (Fig 6) . This is compared with an increase in the level of @-globin expression with erythroid maturation.
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Expression (?/MRK protein. We prepared specific polyclonal rabbit antisera to a glutathione-S-transferase fusion protein that contained the C-terminal 41 amino acids of MRK. The specificity of this antisera was tested in plasma membranes prepared from COS cells transfected with an expression plasmid containing the MRK cDNA. The membranes were electrophoresed through an 8% SDS-PAGE gel, transferred to nitrocellulose. and subjected to Western blot analysis. As shown in Fig 7. 
DISCUSSION
Hematopoietic development involves cytokine signaling of cell-surface receptors. We have isolated a novel member of the RTK family that may participate in the regulation of hematopoiesis. The receptor is highly expressed on develop ing erythroblasts and the level remains relatively constant throughout erythroid development. The gene is also expressed in other tissues, including brain, liver, lung, small intestine, stomach, spleen. kidney, testes, and heart. As shown in Fig 5, MRK expression is not detected ubiquitously in hematopoietic cell lines and is not lineage restricted. For instance. bone marrow-derived mast cells and other mast cell lines express high levels of MRK; however, no expression is detected in P8 15 cells. The effects of MRK receptor activation on distinct cell-specific programs therefore remains to be determined.
The extracellular domain of MRK has novel features and is unrelated to any other member of the RTK family. There are only two extracellular cysteines, and no apparent Ig structure: therefore, the ligand-receptor interaction is likely to be novel. In addition, the cytoplasmic domain of MRK contains regions of homology to the c-me! and v-sea oncogenes. Throughout the kinase domain, there is general homology to the EGFR, insulin receptor, AXL, and FGFR. In subdomain I the motif GXGXXG is distinct in MRK, which is QXGXXG. The GXGXXG consensus sequence is present in all but 2 of 117 members of protein kinases.' Because this region borders the ATP binding domain, it is possible this will allow regulation in a distinct manner from the other members of the RTK family. The homology of MRK to the c-met proto-oncogene and v-sea oncogene is interesting, because these genes have been implicated in hematopoietic development and oncogenesis. The v-sea oncogene" was originally isolated from a temperature-sensitive mutant of the avian erythroblastosis virus SI 3. The v-sea product (gp155/70e"V~Sea) is a fusion protein of the tyrosine kinase domain of a novel RTK and the carboxyl terminus ofthe viral envelope gly~oprotein.~~ Erythroleukemias derived from S 13 infection demonstrate synchronous, erythropoietin-dependent differentiation at the nonpermissive temperature, when kinase activity of the vsea fusion protein is almost completely inacti~ated.~~Termi-nal differentiation is associated with a transcriptional activation of erythroid-specific genes such as the globins. At the permissive temperature, the cells grow in a hormone-independent fashion. These cells are frozen at an early stage of erythroid differentiation with low levels of erythroid gene transcription. Many tissues express c-sea, including fibroblast and hematopoietic cell lines. Therefore, activation of this oncogene or proto-oncogene can affect erythroid development.
The me! proto-oncogene was originally isolated from a human osteogenic sarcoma cell line (HOS) treated with a ~arcinogen.~' The activating mutation generated a fusion protein of a translocated promoter region and the MET locus. The c-met proto-oncogene is expressed on some hematopoietic cells and also in a variety of fetal and adult cells.27 High levels are found in the liver. Recently, it was demonstrated that the ligand for the c-met receptor is hepatocyte growth factor, a strong mitogen in primary hepatocyte ~u l t u r e .~"~~ Kinase activity of c-met is mediated by autopho~phorylation.~~ and negatively regulated by protein kinase C and increases in intracellular calcium.56 The c-met oncogene has been shown to be present on bone marrow cells.27 HGF, the ligand for the c-met oncogene, seems to act synergistically with IL-3 and GM-CSF to stimulate colony formation from bone marrow cells in vitro. Based on the structural similarity between MRK, v-sea, and c-met. simiFor personal use only. on January 30, 2018. by guest www.bloodjournal.org From lar cellular substrates may interact with all of these receptors.
MRK is added as a member ofthe rapidly growing family of RTKs.~ These receptors control adiverse pattern of signaling for hematopoietic cells and are likely to be involved in the decision of cell fate and proliferation. As shown in the Western blot analysis in Fig 7, anti-MRK fusion protein antisera recognizes plasma membranes from COS cells transfected with the wild-type MRK cDNA. In addition, the antisera recognizes MRK in immunoprecipitation analyses (data not shown). Future studies using the specific antisera to MRK in immunoprecipitation and immunohistochemistry analyses on tissue specimens and hematopoietic cells will demonstrate the distribution of the MRK protein. Preliminary evidence demonstrates a low level of MRK protein expression on MEL cells and not P8 15 or BAF3 cells (Yee and Zon, unpublished results). The function of the cytoplasmic tail of MRK, which includes the tyrosine kinase domain, is currently being evaluated using a c$ws/MRK chimeric receptor. This chimeric receptor will be expressed in hematopoietic progenitor cell lines, and alterations in cell differentiation, cell potential, and receptor phosphorylation determined in response to M-CSF. Additional studies will characterize the ligand which interacts with the MRK receptor. 
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NOTE ADDED IN PROOF
After the submission of this manuscript, several other investigators have isolated an identical cDNA from the 12.5-day mouse placenta" and peritoneal macrophage RNA.'* In addition, a human homologue has been isolated.59
